X-ZELL Blog Episode 7

X-ZELL Blog CEC research gaining global recognition Less than three months ago, in August 2018, X-ZELL CEO Dr Sebastian Bhakdi took to stage at the 19th Asia-Pacific Prostate Cancer Conference in Brisbane (Australia) to reveal an unexpected breakthrough in early...

X-ZELL Blog Episode 6

X-ZELL Blog Why CEC will revolutionise cancer screening On 15 December 2017, a simple tweet started a scientific revolution that could change our very understanding of early cancer detection. Following years of research, X-ZELL used social media to share the...

X-ZELL Blog Episode 5

X-ZELL Blog MRI's role in prostate cancer screening The role of magnetic resonance imaging (MRI) as a tool to detect and stage clinically significant prostate cancer (csPCa) continues to cause controversy among the medical community. The 19th Asia-Pacific Prostate...

X-ZELL Blog Episode 4

X-ZELL Blog A new way to avoid painful prostate biopsies Friday, 24 August 2018, will go down as a decisive milestone in the history of X-ZELL Inc. – not just because we had the privilege of sharing our latest research with the global scientific community, but also...

X-ZELL Blog Episode 3

X-ZELL Blog Explained: The early detection paradox Even though the notion of discovering prostate cancer early may seem intriguing from a patient perspective, the topic has been dividing the medical community for decades. The sticking point is a simple question – how...

X-ZELL Blog Episode 2

X-ZELL Blog The biotech dilemma Last month, X-ZELL CEO, Dr Sebastian Bhakdi, used his guest speaking spot at the 2018 HealthInvestor Asia Summit to reflect on the opportunities and challenges biotechnology start-ups face in Asia – revealing why so many of them fail to...